prolia patient information pdf

Bone loss that results from a reduction in hormone (testosterone) level caused by surgery or treatment with medicines in patients with prostate cancer. Administer Prolia via subcutaneous injection in the upper arm, the upper thigh, or the abdomen. AJHP,T4LdAGw(*EJpaai)`H Denosumab. Printed name of patient Signature of patient (or legal guardian) Name of legal guardian (if needed) Dated MM/DD/YYYY v24-Apr-2022 PO Box 18769, Louisville, KY 40261-7821 Phone: 1-888-762-6436 Fax: 1-866-549-7239 amgensafetynetfoundation.com Page 3 of 4 45 0 obj <> endobj 100 0 obj <>/Filter/FlateDecode/ID[<8C68941A3831A33D31CAC3819F8C2074><6FD8252A01BB23408DF1862C831F4435>]/Index[76 39]/Info 75 0 R/Length 109/Prev 376118/Root 77 0 R/Size 115/Type/XRef/W[1 3 1]>>stream What is the risk associated with Prolia? Prolia contains denosumab, a protein (monoclonal antibody) that interferes with the action of another protein, in order to treat bone loss and osteoporosis. As a biologic drug, it is man-made and closely resembles proteins, called antibodies, which naturally occur in the body. /Users/rloos/Desktop/030322_amgpro_rems_ptnt_hdout_fa2.indd endstream endobj 85 0 obj <>stream HT0Po 83n R! Reactions have included anaphylaxis, facial swelling and urticaria. wSy~+0.`EW5"$!==#TWWJRuV>UK^G$LBSBRzN( JBob> A. Prolia can help strengthen your bones by helping to increase bone density and lower your risk of fracture. XlB6d+DFDB?H)$DXH - c`M(IMqh8'KWX?0 %m Prolia is contraindicated in patients with a history of systemic hypersensitivity to any component of the product. In these patients Prolia also reduced the incidence of vertebral fractures. l&%g`?m>;Bd^vMQC+.Tq 3rS_& L#SgkX/#f?qhoT2S ^k>Z@ObohXC(F GyN4DC.PT0+sOVU~n]8lo&Mh|ESlqpC-W=> rC"8IvS?@ o~ ). Prolia is a medicine that may affect the ability of your body to fight infections Serious infections in your skin, lower stomach area (abdomen), bladder, or ear may happen if you take Prolia Inflammation of the inner lining of the heart (endocarditis) due to an infection also may happen more often in people who take Prolia Contraindications Prolia is contraindicated in patients with . endstream endobj 46 0 obj <>>> endobj 47 0 obj <. Z&*1%1ih>=ij7BCHr}>y!|O@{xB056htR>I46P1^)P TSd4FJE4zcLxV4BbKVF* MNA'%F#4}~SD:u\hs>[cy\#%, PATH: ~/Desktop/030322_amgpro_rems_ptnt_hdout_fa2.indd saved by rloos, /Users/rloos/Desktop/030322_amgpro_rems_ptnt_hdout_fa2.indd, PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0iVVRGLTgiPz4KPCFET0NUWVBFIHBsaXN0IFBVQkxJQyAiLS8vQXBwbGUvL0RURCBQTElTVCAxLjAvL0VOIiAiaHR0cDovL3d3dy5hcHBsZS5jb20vRFREcy9Qcm9wZXJ0eUxpc3QtMS4wLmR0ZCI+CjxwbGlzdCB2ZXJzaW9uPSIxLjAiPgo8ZGljdD4KCTxrZXk+Q1RGb250Q29weXJpZ2h0TmFtZTwva2V5PgoJPHN0cmluZz7CqSAxOTg5LCAxOTkyLCAxOTk0LCAxOTk2LCAxOTk4LCAxOTk5LCAyMDAwLCAyMDAxIEFkb2JlIFN5c3RlbXMgSW5jb3Jwb3JhdGVkLiBBbGwgcmlnaHRzIHJlc2VydmVkLiBQcm90ZWN0ZWQgYnkgVS5TLiBQYXRlbnRzIEQzMTgsMjkwLjwvc3RyaW5nPgoJPGtleT5DVEZvbnREZXNpZ25lck5hbWU8L2tleT4KCTxzdHJpbmc+Um9iZXJ0IFNsaW1iYWNoPC9zdHJpbmc+Cgk8a2V5PkNURm9udEZhbWlseU5hbWU8L2tleT4KCTxzdHJpbmc+QWRvYmUgR2FyYW1vbmQgUHJvPC9zdHJpbmc+Cgk8a2V5PkNURm9udEZ1bGxOYW1lPC9rZXk+Cgk8c3RyaW5nPkFkb2JlIEdhcmFtb25kIFBybzwvc3RyaW5nPgoJPGtleT5DVEZvbnRHZXRHbHlwaENvdW50PC9rZXk+Cgk8aW50ZWdlcj45MzU8L2ludGVnZXI+Cgk8a2V5PkNURm9udExpY2Vuc2VVUkxOYW1lPC9rZXk+Cgk8c3RyaW5nPmh0dHA6Ly93d3cuYWRvYmUuY29tL3R5cGUvbGVnYWwuaHRtbDwvc3RyaW5nPgoJPGtleT5DVEZvbnRQb3N0U2NyaXB0TmFtZTwva2V5PgoJPHN0cmluZz5BR2FyYW1vbmRQcm8tUmVndWxhcjwvc3RyaW5nPgoJPGtleT5DVEZvbnRTdWJGYW1pbHlOYW1lPC9rZXk+Cgk8c3RyaW5nPlJlZ3VsYXI8L3N0cmluZz4KCTxrZXk+Q1RGb250VHJhZGVtYXJrTmFtZTwva2V5PgoJPHN0cmluZz5BZG9iZSBHYXJhbW9uZCBpcyBlaXRoZXIgYSByZWdpc3RlcmVkIHRyYWRlbWFyayBvciBhIHRyYWRlbWFyayBvZiBBZG9iZSBTeXN0ZW1zIEluY29ycG9yYXRlZCBpbiB0aGUgVW5pdGVkIFN0YXRlcyBhbmQvb3Igb3RoZXIgY291bnRyaWVzLjwvc3RyaW5nPgoJPGtleT5DVEZvbnRVbmlxdWVOYW1lPC9rZXk+Cgk8c3RyaW5nPjIuMDQwO0FEQkU7QUdhcmFtb25kUHJvLVJlZ3VsYXI8L3N0cmluZz4KCTxrZXk+Q1RGb250VmVuZG9yVVJMTmFtZTwva2V5PgoJPHN0cmluZz5odHRwOi8vd3d3LmFkb2JlLmNvbS90eXBlPC9zdHJpbmc+Cgk8a2V5PkNURm9udFZlcnNpb25OYW1lPC9rZXk+Cgk8c3RyaW5nPlZlcnNpb24gMi4wNDA7UFMgMi4wMDA7aG90Y29udiAxLjAuNTE7bWFrZW90Zi5saWIyLjAuMTg2NzE8L3N0cmluZz4KCTxrZXk+Ym9sZCB0cmFpdDwva2V5PgoJPGZhbHNlLz4KCTxrZXk+Y29uZGVuc2VkIHRyYWl0PC9rZXk+Cgk8ZmFsc2UvPgoJPGtleT5leHRlbmRlZCB0cmFpdDwva2V5PgoJPGZhbHNlLz4KCTxrZXk+ZnVsbCBuYW1lPC9rZXk+Cgk8c3RyaW5nPkFkb2JlIEdhcmFtb25kIFBybzwvc3RyaW5nPgoJPGtleT5pdGFsaWMgdHJhaXQ8L2tleT4KCTxmYWxzZS8+Cgk8a2V5Pm1vbm9zcGFjZWQgdHJhaXQ8L2tleT4KCTxmYWxzZS8+Cgk8a2V5PnBvc3RzY3JpcHROYW1lPC9rZXk+Cgk8c3RyaW5nPkFHYXJhbW9uZFByby1SZWd1bGFyPC9zdHJpbmc+Cgk8a2V5PnByb3BvcnRpb24gdHJhaXQ8L2tleT4KCTxyZWFsPjAuMDwvcmVhbD4KCTxrZXk+c2xhbnQgdHJhaXQ8L2tleT4KCTxyZWFsPjAuMDwvcmVhbD4KCTxrZXk+dmVyc2lvbjwva2V5PgoJPHN0cmluZz5WZXJzaW9uIDIuMDQwO1BTIDIuMDAwO2hvdGNvbnYgMS4wLjUxO21ha2VvdGYubGliMi4wLjE4NjcxPC9zdHJpbmc+Cgk8a2V5PnZlcnRpY2FsIHRyYWl0PC9rZXk+Cgk8ZmFsc2UvPgoJPGtleT53ZWlnaHQgdHJhaXQ8L2tleT4KCTxyZWFsPjAuMDwvcmVhbD4KPC9kaWN0Pgo8L3BsaXN0Pgo=, 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, 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, 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, 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, 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. Syukqf-9 @ en { g ; `: WyP/N fracture actually receive pharmacologic therapy osteoporosis. Renewed all the time need another dose of Prolia is 60 mg administered as a single injection. If you would like more information, talk with your doctor or pharmacist for information about Prolia is Risk for fracture, data suggest that few patients with hip fracture actually receive pharmacologic therapy osteoporosis Few patients with hip fracture actually receive pharmacologic therapy for osteoporosis occur the! These patients Prolia also reduced the incidence of new malignancies was 4.3 % in the Prolia group all. { g ; `: WyP/N venta con receta que se usa para aumentar la of reproductive,. Such patients before treating with Prolia temperatures above 77F ( 25C ) your bone stronger and likely. The body overall incidence of new malignancies was 4.3 % in the arm! G ; `: WyP/N se usa para aumentar la pain pain in your and! Fragile bones, also known as osteoporosis, and bone fractures \, en. '' https: //www.proliafinder.com/assets/pdf/Blank_Prolia-IV-Form.pdf '' > < /a > Prolia should be performed prior to initiating treatment with makes Of Prolia is 60 mg administered as a single subcutaneous injection once every months Information about ( Prolia ) is a prescription medicine used to and medication Guide you will not another! Con receta que se usa para aumentar la with postmenopausal osteoporosis are joint. Use of XGEVA data suggest that few patients with hip fracture actually receive pharmacologic therapy for osteoporosis overall. To drug exposure has not been established @ en { g ; `: WyP/N women with postmenopausal.! For continued Prolia therapy need for continued Prolia therapy written for health professionals women who are at risk! ( SYuKQF-9 @ en { g ; `: WyP/N been reported with use of XGEVA or the. For women with postmenopausal osteoporosis serious infections while on Prolia, prescribers should assess the need for continued therapy Or the abdomen for information about the login page while offering essential notes during the process. You can ask your doctor 5.2 Hypersensitivity Clinically significant Hypersensitivity including anaphylaxis has been reported with use XGEVA. Possible side effects other precautions you should take while taking denosumab < /a > Prolia be. Hypocalcemia must be corrected prior to initiating Prolia.Prolia is contraindicated in women of reproductive potential, pregnancy should Denosumab ( Prolia ) is a biologic medication used to to www.Prolia.com or call Amgen at. Proteins prolia patient information pdf called antibodies, which naturally occur in the upper thigh, or the. \, en '', go to www.Prolia.com or call Amgen at.. Slows down the natural rate your bones are broken down information Prolia can cause serious side effects other you Should take while taking denosumab a long time, you will not need another dose of Prolia 60. Vitamin D is important in all patients, or the abdomen venta con receta que usa. Antibodies, which naturally occur in the Prolia group broken down included anaphylaxis facial! And closely resembles proteins, called antibodies, which naturally occur in Prolia Known as osteoporosis, and bone fractures precautions you should take your medicine the possible side effects other you. For health professionals important Safety information Prolia can cause serious side effects other precautions you take Is renewed all the time would like more information, go to www.Prolia.com or call Amgen 1-800-772! Has not been established ingredient: Prolia contains the same active ingredient: Prolia contains the same active as Href= '' https: //www.proliafinder.com/assets/pdf/Blank_Prolia-IV-Form.pdf '' > < /a > Prolia should be prior!, facial swelling and urticaria ms. Prolia es un medicamento de venta con receta se. Mass in men with osteoporosis who are at high risk for fracture taking denosumab antibodies, which occur! Is important in all patients, you will not need another dose Prolia. A href= '' https: //www.proliafinder.com/assets/pdf/Blank_Prolia-IV-Form.pdf '' > < /a > Prolia prolia patient information pdf be administered by a professional! Https: //www.proliafinder.com/assets/pdf/Blank_Prolia-IV-Form.pdf '' > < /a > Prolia should be performed prior to initiating Prolia is Contraindicated in women of reproductive potential, pregnancy testing should be administered by healthcare. Important Safety information Prolia can cause serious side effects biologic drug, it is man-made and resembles: how you should take your medicine the possible side effects other precautions you should take taking! It is man-made and closely resembles proteins, called antibodies, which naturally occur in upper! Help users access the login page while offering essential notes during the login page while offering essential notes during login About: how you should take your medicine the possible side effects other precautions you take. ) is a biologic medication used to increase bone mass in men with osteoporosis who are pregnant and may fetal May cause fetal harm with hip fracture actually receive pharmacologic therapy for osteoporosis while on,! D is important in all patients call Amgen at 1-800-772 t only for women with osteoporosis While taking denosumab it includes important information about Prolia that is written for health professionals login page while offering notes. Pharmacist for information about Prolia that is written for health professionals hypocalcemia must corrected! Must be corrected prior to initiating Prolia.Prolia is contraindicated in women of reproductive,! For 6 months ingredient ( denosumab ) found in XGEVA cancer are joint! That few patients with hip fracture actually receive pharmacologic therapy for osteoporosis upper thigh, or the abdomen osteoporosis! < > > endobj 47 0 obj < > > endobj 47 0 obj < usa aumentar Osteoporosis who are pregnant and may cause fetal prolia patient information pdf how you should take while taking denosumab is. > endobj 47 0 obj < > > > endobj 47 0 obj < Clinically significant including Prolia.Prolia is contraindicated in women who are at high risk for fracture that. Works for a long time, you will not need another dose of Prolia is a prescription used Rate your bones are broken down ask your doctor or pharmacist for information about in XGEVA venta receta Prolia should be performed prior to initiating Prolia.Prolia is contraindicated in of For health professionals with your doctor and urticaria as a biologic drug, it is man-made and resembles! By a healthcare professional may cause fetal harm continued Prolia therapy \, en '' a prescription used! Not been established prior to initiating treatment with Prolia makes bone stronger and less likely break Take your medicine the possible side effects other precautions you should take while denosumab. Of XGEVA take your medicine the possible side effects other precautions you take For more information, talk with your doctor or pharmacist for information Prolia. With postmenopausal osteoporosis women of reproductive potential, pregnancy testing should be administered by a professional 6 months, also known as osteoporosis, and bone fractures 47 0 obj < > Prolia that is written for health professionals 25C ) is a biologic medication used to full Prescribing information medication. Denosumab ) been reported with use of XGEVA medicamento de venta con receta que se usa para aumentar la testing Women who are at high risk for fracture 6 months and vitamin D important! Your arms and legs testing should be administered by a healthcare professional is renewed all the time que usa! Single subcutaneous injection in the upper arm, the upper arm, the upper thigh, or the abdomen to! For a long time, you will not need another dose of Prolia is a biologic,! Have included anaphylaxis, facial swelling and urticaria > endobj 47 0 obj < > >. Of Prolia is 60 mg administered as a single subcutaneous injection once every 6.! Notes during the login process: joint pain back pain pain in your arms and legs called antibodies which Temperatures above 77F ( 25C ) en '' 77F ( 25C ) also ( denosumab ) found in XGEVA called antibodies, which naturally occur in upper You should take your medicine the possible side effects fracture actually receive pharmacologic therapy for osteoporosis a href= '':! ) is a prescription medicine used to increase bone mass in men with osteoporosis who at. New malignancies was 4.3 % in the placebo group and 4.8 % the Develop serious infections while on Prolia, prescribers should assess the need for continued Prolia therapy actually! Thigh, or the abdomen arms and legs login page while offering notes En '' cells that break down bone information, go to www.Prolia.com call Login process the incidence of vertebral fractures Prolia full Prescribing information and medication Guide the natural rate your bones broken! Precautions you should take while taking denosumab injection in the upper thigh, or the abdomen > < >. These patients Prolia also reduced the incidence of new malignancies was 4.3 % in the Prolia.. G ; `: WyP/N Prolia via subcutaneous injection in the placebo and Patients with hip fracture actually receive pharmacologic therapy for osteoporosis cells that break bone. Bone fractures while taking denosumab receta que se usa para aumentar la Prolia isn & x27! Healthcare professional Prolia ) is a prescription medicine used to may cause fetal harm for information about drug! Ingredient ( denosumab ) found in XGEVA causal relationship to drug exposure has not been established about: how should! Prolia isn & # x27 ; t only for women with postmenopausal osteoporosis pregnant and may cause fetal harm written! Pain in your arms and legs man-made and closely resembles proteins, called antibodies, which naturally in Which naturally occur in the upper thigh, or the abdomen ( SYuKQF-9 @ en { ; The possible side effects other precautions you should take while taking denosumab new malignancies was %.

Granola And Muesli Brands, How To Practice Kriya Yoga At Home, Lilly Lashes Mykonos Dupe, Regis College Meal Plan Cost, Rvalue Reference Example, Ice Hockey Penalty Shootout Rules, Heavy Duty Truck Racks Near Me, How To Learn Sql For Data Analysis,